New inhaled therapy shows promise in slowing deadly lung disease progression
Disease control
Completed
This study tested whether an inhaled medication called treprostinil could help people with idiopathic pulmonary fibrosis, a progressive lung scarring disease. 598 participants either received the active medication or a placebo inhaler for 52 weeks to see if it could slow the decl…
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 06, 2026 14:19 UTC